Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-100,000
Closed -$2.96M 4866
2021
Q1
$2.96M Buy
100,000
+65,200
+187% +$1.87M ﹤0.01% 1956
2020
Q4
$994K Sell
34,800
-12,000
-26% -$327K ﹤0.01% 2768
2020
Q3
$1.04M Sell
46,800
-3,900
-8% -$90.4K ﹤0.01% 2658
2020
Q2
$1.14M Sell
50,700
-23,100
-31% -$473K ﹤0.01% 2637
2020
Q1
$1.27M Buy
73,800
+59,600
+420% +$1.52M ﹤0.01% 2714
2019
Q4
$432K Buy
+14,200
New +$419K ﹤0.01% 4416
2019
Q3
Sell
-265,600
Closed -$7.91M 6701
2019
Q2
$7.91M Buy
+265,600
New +$7.04M ﹤0.01% 1509
2019
Q1
Sell
-100,000
Closed -$2.34M 7003
2018
Q4
$2.34M Buy
100,000
+99,000
+9,900% +$2.46M ﹤0.01% 2250
2018
Q3
$29K Buy
+1,000
New +$30K ﹤0.01% 6324

Other funds holding AXTA

Barclays's AXTA Position: Q1 2026 in Review

Barclays reduced its Axalta (AXTA) stake by 66% in Q1 2026, selling an estimated $6.33M and leaving 104,287 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2138.

Barclays first reported a position in AXTA in Q4 2014 and has held it in 45 quarters since. The position peaked at $29.6M in Q2 2018. 381 funds tracked by Wall St. Rank hold AXTA as of Q1 2026.

  • Barclays held 104,287 shares of Axalta worth $2.89M as of Q1 2026.
  • Barclays sold 199,450 Axalta shares in Q1 2026, an estimated $6.33M.
  • Axalta made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2138 holding.
  • Barclays first reported a position in Axalta in Q4 2014 and has held it in 45 quarters since.
  • Barclays's Axalta position peaked at $29.6M in Q2 2018.
  • 381 funds tracked by Wall St. Rank held Axalta as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.